Effects of Oveporexton, an Orexin Receptor 2–Selective Agonist, on Cognition in Narcolepsy Type 1

This secondary analysis of the TAK-861-2001 randomized clinical trial explores the effect of oveporexton, an oral orexin receptor 2–selective agonist, on cognition in people with narcolepsy type 1.

Läs hela artikeln: Visa original